Aveanna Healthcare Holdings Inc. Stock

Equities

AVAH

US05356F1057

Healthcare Facilities & Services

Market Closed - Nasdaq 04:00:00 2024-04-19 pm EDT 5-day change 1st Jan Change
2.29 USD +6.02% Intraday chart for Aveanna Healthcare Holdings Inc. -2.14% -14.55%
Sales 2024 * 1.97B Sales 2025 * 2.08B Capitalization 441M
Net income 2024 * -22M Net income 2025 * -3M EV / Sales 2024 * 0.89 x
Net Debt 2024 * 1.31B Net Debt 2025 * 1.31B EV / Sales 2025 * 0.84 x
P/E ratio 2024 *
-19.1 x
P/E ratio 2025 *
-641 x
Employees 33,500
Yield 2024 *
-
Yield 2025 *
-
Free-Float 47.44%
More Fundamentals * Assessed data
Dynamic Chart
Aveanna Healthcare Holdings Inc Announces Appointment of Jerry Perchik to Serve as Chief Legal Officer and Secretary, Effective April 29, 2024 CI
Deutsche Bank Adjusts Aveanna Healthcare Price Target to $3 From $2, Maintains Buy Rating MT
Aveanna Healthcare Holdings Inc. Seeks Small M&A Tuck-Ins CI
Transcript : Aveanna Healthcare Holdings Inc., Q4 2023 Earnings Call, Mar 14, 2024
Aveanna Healthcare Holdings Inc. Provides Earnings Guidance for the Full Year 2024 CI
Aveanna Healthcare Holdings Inc. Reports Goodwill, Intangible and Other Long-Lived Asset Impairment for the Fourth Quarter Ended December 30, 2023 CI
Aveanna Healthcare Holdings Inc. Reports Earnings Results for the Full Year Ended December 30, 2023 CI
Aveanna Healthcare Holdings Inc. Reports Earnings Results for the Fourth Quarter Ended December 30, 2023 CI
Aveanna Healthcare Holdings Inc. Announces Termination of Shannon Drake as Chief Legal Officer and Secretary, Effective March 31, 2024 CI
North American Morning Briefing : Dow Set For New -2- DJ
JPMorgan Downgrades Aveanna Healthcare to Underweight From Neutral MT
Aveanna Healthcare Names Matt Buckhalter Finance Chief MT
Aveanna Healthcare Holdings Inc. Appoints Matthew Buckhalter as Chief Financial Officer and Principal Financial Officer ,Effective January 1, 2024 CI
UBS Initiates Coverage on Aveanna Healthcare With Sell Rating, $1.50 Price Target MT
Transcript : Aveanna Healthcare Holdings Inc., Q3 2023 Earnings Call, Nov 09, 2023
More news

Latest transcript on Aveanna Healthcare Holdings Inc.

1 day+6.02%
1 week-2.14%
Current month-8.03%
1 month-7.29%
3 months-1.29%
6 months+80.31%
Current year-14.55%
More quotes
1 week
2.11
Extreme 2.11
2.39
1 month
2.11
Extreme 2.11
2.66
Current year
2.00
Extreme 2
2.85
1 year
0.85
Extreme 0.85
3.00
3 years
0.67
Extreme 0.6664
13.00
5 years
0.67
Extreme 0.6664
13.00
10 years
0.67
Extreme 0.6664
13.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 17-03-25
Director of Finance/CFO 35 -
Compliance Officer 68 17-05-25
Members of the board TitleAgeSince
Director/Board Member 65 17-05-25
Director/Board Member 77 17-05-25
Director/Board Member 59 17-05-25
More insiders
Date Price Change Volume
24-04-19 2.29 +6.02% 150,838
24-04-18 2.16 -2.70% 85,079
24-04-17 2.22 -2.63% 97,775
24-04-16 2.28 -0.44% 19,450
24-04-15 2.29 -2.14% 79,570

Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT

More quotes
Aveanna Healthcare Holdings Inc. is a provider of diversified home care platform. The Company provides a range of specialized clinical care and non-clinical services to address the complex needs of each patient it serves across the full range of patient populations: newborns, children, adults and seniors. It has three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. HHH segment provides home health, hospice and specialty program services to predominately elderly populations seeking compassionate care and assistance with activities of daily living in the home. Medical Solutions segment provide needed supplies to patients requiring enteral nutrition services or respiratory care. Enteral nutrition (tube or intravenous (IV)) feeding, is a way of delivering nutrition directly to the stomach or small intestine on an as-needed basis.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
2.16 USD
Average target price
2.57 USD
Spread / Average Target
+18.98%
Consensus